3-Bromopyridine-2(1H)-thione

Catalog No.: 
ACRKLC845
CAS No.: 
65938-86-5
Molecular Formula: 
C5H4BrNS
Molecular Weight: 
190.07
3-Bromopyridine-2(1H)-thione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$63.00In stockIn stock
5g98%$297.00In stockIn stock
25g98%$920.00In stockIn stock
100g98%$3532.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromopyridine-2(1H)-thione
IUPAC Name3-bromopyridine-2-thiol
MDL No.MFCD14651478
Molecular FormulaC5H4BrNS
Molecular Weight190.07
SMILESSC1=NC=CC=C1Br
InChI KeyDYSAQUBMKLAXTJ-UHFFFAOYSA-N
Synonym2(1H)-Pyridinethione, 3-bromo- | A918164 | DYSAQUBMKLAXTJ-UHFFFAOYSA-N | EN300-80846 | 2-mercapto-3-bromo-pyridine | 3-Bromopyridine-2(1H)-thione | MFCD14651478 | 3-bromo-1,2-dihydropyridine-2-thione | SY192407 | BS-29369 | AKOS008146319 | 3-Bromo-2-pyrid
CAS No.65938-86-5
PubChem CID12383434

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRKLC845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  2. Then
  3. ACRKLC845 route product structure diagram
    ACRKLC84565938-86-5In Stock
Inquiry

2. ACRKLC845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHTRE764 route compound structure diagram
    ACHTRE76452200-48-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKLC845 route product structure diagram
    ACRKLC84565938-86-5In Stock
Inquiry

3. ACRKLC845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRKLC845 route product structure diagram
    ACRKLC84565938-86-5In Stock
Inquiry

Comments (0)